AUG 11, 2026 · PHASE 1 TRIAL
M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors
ClinicalTrials.gov
First-in-human Phase 1 study with no results posted; designed to establish safety, tolerability, and recommended dose rather than to prove efficacy.
Reported
Estimated enrollment77
Study phasePhase 1
Primary outcome (Parts 1 and 2)Number of Participants With Dose Limiting T…